Mutsuhiro IKUMA

Pharmaceuticals and Medical Devices Agency

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2024

Year:

2023

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (2)

Yasuhiro Fujiwara

Chief Executive

Pharmaceuticals and Medical Devices Agency

JAPAN

View details

Mototsugu Tanaka

Associate Professor

Niigata University Medical and Dental Hospital

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Mutsuhiro IKUMA

Research Interests

Explore related searches

Contact this professor

Articles (10)

Concordance Between Pharmaceuticals and Medical Devices Agency Review and Ministry of Health, Labour and Welfare Decision Among New Drug Applications in Japan

Postmarket safety communications on drugs approved in Japan: A 25-year analysis

Conditional early approval for new drug applications in Japan: Current and emerging issues

Achievements and challenges of the Sakigake designation system in Japan

Rationales of delay and difference in regulatory review by Japan, the USA and Europe among new drugs first approved in Japan

The PMDA’s view on the limited pipeline of nephrology drugs in Japan

The PMDA Perspectives on New Oral Prolyl Hydroxylase Domain Enzyme Inhibitors for Renal Anemia

Assessment of the impact of Japanese-specific long-term safety data on new drug approval

Evolving Landscape of New Drug Approval in Japan and Lags from International Birth Dates: Retrospective Regulatory Analysis

Collaborators (2)

Yasuhiro Fujiwara

Mototsugu Tanaka

Make your next move.